Company research
QuidelOrtho Corp
CIK 1906324Updated Sep 24, 2026
SecurityQDEL · NASDAQ · equity
Name history
Coronado Topco, Inc. · through Apr 11, 2022
QDEL price & chart
Loading TradingView…
NASDAQ:QDEL on TradingView ↗About the company
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes - from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
In the news
QuidelOrtho Reports Third Quarter 2025 Financial Results News provided by QuidelOrtho Corporation Nov 05, 2025, 16:05 ET Share this article Share to X Share this article Share to X ― Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating ↗
Recent filings
Entry into a Material Definitive Agreement
Items 1.01, 9.01
4 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 5,769,300,000Source | 6,423,600,000Source | 8,563,100,000Source | 2,430,400,000Source |
| Property, Plant and Equipment, NetUSD | — | — | 1,443,800,000Source | 349,200,000Source |
| GoodwillUSD | 0Source | 649,500,000Source | 2,492,000,000Source | 337,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,563,800,000Source | 2,735,600,000Source | 2,934,300,000Source | 98,700,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 169,800,000Source | 98,300,000Source | 118,900,000Source | 802,800,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 417,000,000Source | 282,400,000Source | 303,300,000Source | 378,000,000Source |
| Inventory, NetUSD | 577,600,000Source | 533,700,000Source | 577,800,000Source | 198,800,000Source |
| Assets, CurrentUSD | 1,447,300,000Source | 1,218,900,000Source | 1,310,500,000Source | 1,440,300,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 250,500,000Source | 262,400,000Source | 262,100,000Source | 35,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 155,500,000Source | 168,700,000Source | 169,600,000Source | 127,600,000Source |
| Other Assets, NoncurrentUSD | 244,400,000Source | 270,700,000Source | 179,600,000Source | 19,600,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,848,800,000Source | 3,439,100,000Source | 3,557,200,000Source | 501,000,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 100,000Source | 100,000Source | 100,000Source | 0Source |
| Additional Paid in CapitalUSD | 2,931,800,000Source | 2,884,800,000Source | 2,848,000,000Source | 279,800,000Source |
| Retained Earnings (Accumulated Deficit)USD | -996,000,000Source | 135,800,000Source | 2,187,800,000Source | 1,649,200,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -15,400,000Source | -36,200,000Source | -30,000,000Source | 400,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,920,500,000Source | 2,984,500,000Source | 5,005,900,000Source | 1,929,400,000Source |
| Liabilities and EquityUSD | 5,769,300,000Source | 6,423,600,000Source | 8,563,100,000Source | 2,430,400,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 966,100,000Source | 998,800,000Source | 833,800,000Source | 323,500,000Source |
| Operating Lease, Liability, CurrentUSD | 29,300,000Source | 31,100,000Source | 26,700,000Source | 10,000,000Source |
| Accounts Payable, CurrentUSD | 279,400,000Source | 246,000,000Source | 294,800,000Source | 101,500,000Source |
| Operating Lease, Liability, NoncurrentUSD | 154,400,000Source | 167,200,000Source | 172,800,000Source | 128,600,000Source |
| Deferred Income Tax Liabilities, NetUSD | 90,000,000Source | 76,500,000Source | 192,200,000Source | 0Source |
| Other Liabilities, NoncurrentUSD | 166,400,000Source | 55,300,000Source | 83,600,000Source | 48,500,000Source |
| Additional Financial Items | ||||
| Deferred Revenue, CurrentUSD | 37,800,000Source | 33,500,000Source | 36,800,000Source | 1,900,000Source |
| Deferred Revenue, NoncurrentUSD | 16,900,000Source | 17,300,000Source | 13,900,000Source | — |
| Deferred Tax Liabilities, NetUSD | 89,700,000Source | 76,500,000Source | 166,300,000Source | — |
| Long-term DebtUSD | 2,697,700,000Source | 2,488,600,000Source | 2,422,600,000Source | — |
| Long-term Debt, Current MaturitiesUSD | 178,300,000Source | 341,800,000Source | 139,800,000Source | 300,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 442,000,000Source | 453,400,000Source | 457,200,000Source | 52,700,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 45,900,000Source | 42,100,000Source | 51,600,000Source | 25,400,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 117,500,000Source | -5,400,000Source | -160,000,000Source | -118,900,000Source |
| Increase (Decrease) in InventoriesUSD | 148,300,000Source | 134,100,000Source | 211,600,000Source | 85,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | 40,000,000Source | -23,400,000Source | 3,000,000Source | 10,400,000Source |
| Deferred Income Tax Expense (Benefit)USD | 100,000Source | -105,400,000Source | -4,500,000Source | 2,600,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 105,200,000Source | 83,000,000Source | 280,200,000Source | 805,900,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -192,700,000Source | -149,900,000Source | -187,600,000Source | -319,500,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 11,000,000Source | 20,000,000Source | 10,000,000Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 188,200,000Source | 195,100,000Source | 209,300,000Source | 292,800,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 5,400,000Source | 9,600,000Source | 13,500,000Source | 37,100,000Source |
| Payments for Repurchase of Common StockUSD | 0Source | 0Source | 7,200,000Source | 103,500,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 155,800,000Source | 48,800,000Source | -265,800,000Source | -173,100,000Source |
| Repayments of Long-term DebtUSD | 2,289,200,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 71,300,000Source | -21,000,000Source | -174,400,000Source | 312,900,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 169,800,000Source | 98,500,000Source | 119,500,000Source | 802,800,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 172,400,000Source | 177,500,000Source | 150,000,000Source | 0Source |
| Income Taxes Paid, NetUSD | -25,400,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,000,000Source | -2,900,000Source | -1,200,000Source | -400,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 45,500,000Source | 42,400,000Source | 63,800,000Source | 25,400,000Source |
| Amortization of Intangible AssetsUSD | 189,200,000Source | 203,400,000Source | 204,800,000Source | 27,400,000Source |
| Capitalized Computer Software, AmortizationUSD | 3,600,000Source | 2,700,000Source | 600,000Source | 1,000,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 252,800,000Source | 250,000,000Source | 252,400,000Source | 24,300,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | 0Source | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | -1,200,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -5,100,000Source | 0Source | 0Source | 0Source |
| GoodwillUSD | 0Source | 649,500,000Source | 2,492,000,000Source | 337,000,000Source |
| Goodwill, Impairment LossUSD | 700,700,000Source | 1,822,600,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | 2,500,000Source | 700,000Source | -3,600,000Source | 1,500,000Source |
| Income Tax Expense (Benefit)USD | 24,100,000Source | -79,500,000Source | -19,000,000Source | 196,100,000Source |
| InterestExpenseNonoperatingUSD | 177,600,000Source | 163,500,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -1,131,800,000Source | -2,052,000,000Source | -10,100,000Source | 704,200,000Source |
| Other Nonoperating Income (Expense)USD | -5,800,000Source | -7,100,000Source | -20,600,000Source | 100,000Source |
| Proceeds from Issuance of Common StockUSD | 6,100,000Source | 5,000,000Source | 11,600,000Source | 7,600,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 2,997,800,000Source | 1,698,600,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 2,730,200,000Source | 2,782,900,000Source | 2,997,800,000Source | 1,698,600,000Source |
| Selling, General and Administrative ExpenseUSD | 746,300,000Source | 766,800,000Source | 763,200,000Source | 239,600,000Source |
| Operating Income (Loss)USD | -919,200,000Source | -1,960,900,000Source | 139,100,000Source | 906,000,000Source |
| Other Nonoperating Income (Expense)USD | -5,800,000Source | -7,100,000Source | -20,600,000Source | 100,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -1,107,700,000Source | -2,131,500,000Source | -29,100,000Source | 900,300,000Source |
| Income Tax Expense (Benefit)USD | 24,100,000Source | -79,500,000Source | -19,000,000Source | 196,100,000Source |
| Net Income (Loss) Attributable to ParentUSD | -1,131,800,000Source | -2,052,000,000Source | -10,100,000Source | 704,200,000Source |
| Earnings Per Share, BasicUSD per share | -16.69Source | -30.54Source | -0.15Source | 16.74Source |
| Earnings Per Share, DilutedUSD per share | -16.69Source | -30.54Source | -0.15Source | 16.43Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 67,800,000Source | 67,200,000Source | 66,800,000Source | 42,100,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 67,800,000Source | 67,200,000Source | 66,800,000Source | 42,900,000Source |
| Interest Expense (non-operating)USD | 177,600,000Source | 163,500,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 189,200,000Source | 203,400,000Source | 204,800,000Source | 27,400,000Source |
| Business Combination, Acquisition Related CostsUSD | — | 127,200,000Source | 113,400,000Source | 9,600,000Source |
| Capitalized Computer Software, AmortizationUSD | 3,600,000Source | 2,700,000Source | 600,000Source | 1,000,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | 1,456,000,000Source | 1,496,400,000Source | 1,503,400,000Source | 420,300,000Source |
| Current Income Tax Expense (Benefit)USD | 24,000,000Source | 25,900,000Source | -14,500,000Source | 193,500,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 252,800,000Source | 250,000,000Source | 252,400,000Source | 24,300,000Source |
| Goodwill, Impairment LossUSD | 700,700,000Source | 1,822,600,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -523,800,000Source | -2,167,100,000Source | -163,900,000Source | 891,200,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 2,500,000Source | 700,000Source | -3,600,000Source | 1,500,000Source |
| Interest Income (Expense), NetUSD | — | -163,500,000Source | -147,600,000Source | -5,800,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -177,600,000Source | -163,500,000Source | — | — |
| Interest Income, OtherUSD | 2,200,000Source | 2,600,000Source | 5,500,000Source | 300,000Source |
| Other Cost and Expense, OperatingUSD | 97,700,000Source | 51,800,000Source | 27,100,000Source | 0Source |
| Research and Development ExpenseUSD | 186,200,000Source | 218,700,000Source | 246,800,000Source | 95,700,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 2,997,800,000Source | 1,698,600,000Source |
Filing attachments
qdel62320268-kex991.htm · 8-K · 2026-06-23
EX-99.1 3 qdel62320268-kex991.htm EX-99.1 Document Exhibit 99.1 QuidelOrtho Appoints Micah Young as Chief Financial Officer Seasoned medical technology finance executive brings more than two decades of leadership at global public companies June 23, 2026 SAN DIEGO, CA - QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho” or the “Company”), a leading global provider of diagnostic solutions, today announced the appointment of Micah Young as Chief Financial Officer, effective July 6, 2026…
Read attachment ↗d89902dex991.htm · 8-K · 2026-03-24
EX-99.1 2 d89902dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer March 24, 2026 SAN DIEGO, CA - QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global leader of in vitro diagnostics, is pleased to announce the appointment of Nathaniel “Nate” Sisitsky as its new Chief Legal Officer, effective March 23, 2026. He will report to Brian Blaser, President and Chief Executive Officer, and will lead QuidelOrtho’s global…
Read attachment ↗